WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001038579) METHOD OF IDENTIFYING TOXIC AGENTS USING NSAID-INDUCED DIFFERENTIAL GENE EXPRESSION IN LIVER
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/038579    International Application No.:    PCT/US2000/032049
Publication Date: 31.05.2001 International Filing Date: 21.11.2000
Chapter 2 Demand Filed:    19.06.2001    
IPC:
C12Q 1/68 (2006.01)
Applicants: CURAGEN CORPORATION [US/US]; 555 Long Wharf Drive, 11th floor, New Haven, CT 06511 (US) (For All Designated States Except US).
GOULD-ROTHBERG, Bonnie, E. [CA/US]; (US) (For US Only).
DIPIPPO, Vincent, A. [US/US]; (US) (For US Only).
RAMSEH, Tennore, M. [IN/US]; (US) (For US Only).
GERWEIN, Robert, W. [US/US]; (US) (For US Only)
Inventors: GOULD-ROTHBERG, Bonnie, E.; (US).
DIPIPPO, Vincent, A.; (US).
RAMSEH, Tennore, M.; (US).
GERWEIN, Robert, W.; (US)
Agent: ELRIFI, Ivor, R.; Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., One Financial Center, Boston, MA 02111 (US)
Priority Data:
60/166,923 22.11.1999 US
60/183,531 18.02.2000 US
09/717,321 20.11.2000 US
Title (EN) METHOD OF IDENTIFYING TOXIC AGENTS USING NSAID-INDUCED DIFFERENTIAL GENE EXPRESSION IN LIVER
(FR) METHODE D'IDENTIFICATION D'AGENTS TOXIQUES UTILISANT L'EXPRESSION GENETIQUE DIFFERENTIELLE INDUITE PAR LES ANTI-INFLAMMATOIRES NON STEROIDIENS (AINS) DANS LE FOIE
Abstract: front page image
(EN)The invention provides methods of identifying toxic agents, e.g., hepatotoxic agents, using differential gene expression. Also provided are methods of predicting the risk level and or injury type of NSAIDs. Also disclosed are novel nucleic acid sequences whose expression is differentially regulated by NSAIDs.
(FR)L'invention concerne des méthodes d'identification d'agents toxiques, par exemple des agents hépatotoxiques, utilisant l'expression génétique différentielle. L'invention concerne également des méthodes de prévision du niveau de risque et/ou du type de lésion associés aux AINS. L'invention concerne enfin de nouvelles séquences d'acide nucléique dont l'expression est régulée de manière différentielle par les AINS.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, US, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)